SCHEMBL8901062

SCHEMBL8901062

c1ccc(Nc2nc(Nc3ccc(-c4ccccc4)cc3)nc3ccccc23)cc1

nearest known ligand 0.84

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 9/20 0.84
ABCG2 Q9UNQ0 3/20 0.64
MEN1 O00255 1/20 0.64
KMT2A Q03164 1/20 0.64
PDE5A O76074 2/20 0.62
SLC2A1 P11166 1/20 0.61
USP2 O75604 1/20 0.57
ALDH1A1 P00352 1/20 0.57
LMNA P02545 1/20 0.57
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
TSHR P16473 1/20 0.57
CLK4 Q9HAZ1 1/20 0.57
POLB P06746 1/20 0.57
HTT P42858 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
TAAR1 Q96RJ0 1/20 0.57
KDM1A O60341 1/20 0.57
PIN1 Q13526 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8900034 0.98 NPY5R (0.81) NPY5RABCG2MEN1KMT2APDE5A
SCHEMBL2591063 0.92 NPY5R (1.00) NPY5RABCG2MEN1KMT2APDE5A
Hydrochloric Acid SCHEMBL6039677 0.90 NPY5R (0.96) NPY5RABCG2MEN1KMT2APDE5A
SCHEMBL8898077 0.87 NPY5R (0.84) NPY5RABCG2MEN1KMT2APDE5A
SCHEMBL8897789 0.86 NPY5R (0.66) NPY5RABCG2MEN1KMT2APDE5A
Hydrochloric Acid SCHEMBL8900449 0.86 NPY5R (0.81) NPY5RMEN1KMT2APDE5ASLC2A1
Hydrochloric Acid SCHEMBL8898758 0.86 NPY5R (0.81) NPY5RABCG2KMT2APDE5ASLC2A1
SCHEMBL8890734 0.86 NPY5R (0.81) NPY5RABCG2MEN1KMT2ASLC2A1
SCHEMBL8890555 0.86 NPY5R (1.00) NPY5RABCG2MEN1KMT2APDE5A
SCHEMBL8890945 0.86 NPY5R (1.00) NPY5RABCG2MEN1KMT2ASLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997020822-A1 QUINAZOLIN-2,4-DIAZIRINES AS NPY RECEPTOR ANTAGONIST NOVARTIS AG (CH) 1997-06-12 WO claimed